COPD

COPD Chronic obstructive pulmonary disease (COPD) is the co-occurrence of chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs, causing shortness of breath (dyspnea). In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time.

Obese Non-Smokers Still Face Risks For COPD

By | Mon, 07/07/2014 - 13:15

Obesity increases the risk of chronic obstructive pulmonary disease (COPD), with the strongest risk factor being the measurement of waist circumference.

Are Coughlins More Prone To Pneumonia?

By | Thu, 12/12/2013 - 18:30

A set of Dublin-based researchers prove your health may be determined by your name.

Drugs That Increase The Risk Of Birth Defects Also Save Mothers' Lives: Study Shines Light On Tough Decisions For Pregnant Women

By | Wed, 06/12/2013 - 18:53

Mothers on life-saving medications are more and more likely to stop taking them for fear that the drugs increase the risk of birth defects in their children — now researchers are attempting to measure how necessary these drugs are.

FDA Approves GlaxoSmithKline's Breo Ellipta For Chronic Obstructive Pulmonary Disease

By | Fri, 05/10/2013 - 12:55

The FDA-approved inhaler is now available to treat the lung disease COPD.

New Medicare Payment Reductions And Penalties Draw Criticism

By | Sun, 04/28/2013 - 13:19

Proposed changes to Medicare and Medicaid will result in lower payments to hospitals with poor patient safety and hospitals that serve low-income patients.

CDC Releases Second Round of Anti-Smoking PSAs Targeting Secondhand Smoke

By | Thu, 03/28/2013 - 14:56

The Center's for Disease Control and Prevention has launched its second anti-smoking campaign aimed at second hand smoking.

Water Exercise Boosts Endurance in COPD

By | Fri, 10/05/2012 - 14:18

Water workouts may trump land-based exercise for people with chronic lung disease and other health problems.

Vitamin C May Lower the Effects of Air Pollution

By | Fri, 08/17/2012 - 17:08

Here's another reason to embrace a diet rich in fruit and vegetables: the nutrients in them can help keep away the negative effects of air pollution.

GSK's Combination Lung Drug Shows Positive Results

By | Mon, 07/02/2012 - 17:19

GlaxoSmithKline's experimental once-daily lung drug LAMA/LABA showed positive results on Monday from late stage trials in patients with chronic obstructive pulmonary disease (COPD).

Discovery May Help Ex-Smokers Heal

By | Thu, 01/12/2012 - 13:16

A new discovery may lead to a treatment for improving lung function in smokers.

Antibiotic Found to Reduce COPD Exacerbation

By | Thu, 09/01/2011 - 13:28

A common antibiotic has been found to reduce acute symptoms of chronic obstructive pulmonary disease

Underlying Conditions of COPD Continue After Person Quits Smoking

By | Thu, 07/28/2011 - 10:27

According to Australian researchers, cigarette smoke exposure permanently alters the cellular structure of the tissues in the airway from people with Chronic Obstructive Pulmonary Disease (COPD). Causing airway thickening and even causing precancerous cells to increase long after cigarette smoke exposures has ended.

Study confirms link between rheumatoid arthritis and COPD

By | Thu, 05/26/2011 - 10:10

Patients with rheumatoid arthritis are two times more likely to have concurrent chronic obstructive pulmonary disease (COPD) than healthy controls -- an association which was sustained even when variables such as age, gender, smoking and obesity were controlled for, according to a study presented today at the EULAR 2011 Annual Congress.

'Walking distance' test an accurate indicator of disease severity in patients with COPD

By | Mon, 05/16/2011 - 09:45

The six-minute walking distance test (6MWD), a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease (COPD), according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders

By | Mon, 04/18/2011 - 09:32

Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease (COPD) and several other lung conditions. A scientific paper on Dr. Croft's finding was published online today in the prestigious journal, Nature Medicine.

Pages